Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.7.0.1
Fair Value Measurements (Tables)
3 Months Ended
Apr. 01, 2017
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of April 1, 2017:
(in millions)
Level 1
 
Level 2
 
Total
Assets:
 
 
 
 
 
Cash equivalents
$
3.7

 
$

 
$
3.7

Short-term investments in marketable securities
0.7

 

 
0.7

Restricted cash
11.2

 

 
11.2

Derivatives

 
7.8

 
7.8

Total assets
$
15.6

 
$
7.8

 
$
23.4

 
 
 
 
 
 
Liabilities:
 

 
 

 
 

Derivatives
$

 
$
5.3

 
$
5.3

Deferred compensation
4.4

 
30.0

 
34.4

Total liabilities at fair value
$
4.4

 
$
35.3

 
$
39.7

Liabilities measured at net asset value
 
 
 
 
11.7

Total liabilities
 
 
 
 
$
51.4


The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2016:
(in millions)
Level 1
 
Level 2
 
Total
Assets:
 
 
 
 
 
Cash equivalents
$
4.6

 
$
14.3

 
$
18.9

Short-term investments in marketable securities
0.8

 
35.0

 
35.8

Restricted cash
11.2

 

 
11.2

Derivatives

 
11.2

 
11.2

Total assets
$
16.6

 
$
60.5

 
$
77.1

 
 
 
 
 
 
Liabilities:
 

 
 

 
 

Derivatives
$

 
$
4.8

 
$
4.8

Deferred compensation
4.2

 
28.1

 
32.3

Total liabilities at fair value
$
4.2

 
$
32.9

 
$
37.1

Liabilities measured at net asset value
 
 
 
 
11.6

Total liabilities
 
 
 
 
$
48.7



The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of April 2, 2016:
(in millions)
Level 1
 
Level 2
 
Total
Assets:
 
 
 
 
 
Cash equivalents
$
9.4

 
$

 
$
9.4

Short-term investments in marketable securities
0.8

 

 
0.8

Restricted cash
12.7

 

 
12.7

Derivatives

 
12.5

 
12.5

Total assets
$
22.9

 
$
12.5

 
$
35.4

 
 
 
 
 
 
Liabilities:
 

 
 

 
 

Derivatives
$

 
$
8.4

 
$
8.4

Deferred compensation
3.8

 
36.2

 
40.0

Total liabilities at fair value
$
3.8

 
$
44.6

 
$
48.4

Liabilities measured at net asset value
 
 
 
 
11.6

Total liabilities
 
 
 
 
$
60.0